ロード中...
CMET-34. IMPROVEMENT OF LEPTOMENINGEAL DISEASE FOLLOWING INFECTIOUS MENINGITIS
INTRODUCTION: The incidence of leptomeningeal disease (LMD) is increasing, due to better imaging, earlier diagnosis and improved systemic disease control. However, many of the systemic therapies do not cross the blood brain barrier (BBB) and, despite treatment with radiation and/or intrathecal (IT)...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6847751/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.235 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|